{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:45:27Z","timestamp":1783637127517,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s11102-019-00997-1","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T04:30:17Z","timestamp":1571805017000},"page":"3-8","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pathology of prolactinomas: any predictive value?"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8661-6727","authenticated-orcid":false,"given":"M. Beatriz S.","family":"Lopes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,22]]},"reference":[{"issue":"1","key":"997_CR1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11102-005-5079-0","volume":"8","author":"A Ciccarelli","year":"2005","unstructured":"Ciccarelli A, Daly AF, Beckers A (2005) The epidemiology of prolactinomas. Pituitary 8(1):3\u20136","journal-title":"Pituitary"},{"issue":"8","key":"997_CR2","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jocn.2008.11.001","volume":"16","author":"CG Patil","year":"2009","unstructured":"Patil CG et al (2009) Non-surgical management of hormone-secreting pituitary tumors. J Clin Neurosci 16(8):985\u2013993","journal-title":"J Clin Neurosci"},{"issue":"3","key":"997_CR3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","volume":"72","author":"A Fernandez","year":"2010","unstructured":"Fernandez A, Karavitaki N, Wass JA (2010) Prevalence of pituitary adenomas: a community-based, cross-sectional study in Ban- bury (Oxfordshire, UK). Clin Endocrinol (Oxf) 72(3):377\u2013382","journal-title":"Clin Endocrinol (Oxf)"},{"key":"997_CR4","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1056\/NEJMcp0912025","volume":"362","author":"A Klibanski","year":"2010","unstructured":"Klibanski A (2010) Clinical practice: prolactinomas. N Engl J Med 362:1219\u20131226","journal-title":"N Engl J Med"},{"key":"997_CR5","first-page":"2102","volume":"82","author":"E Delgrange","year":"1997","unstructured":"Delgrange E, Trouillas J, Maiter D et al (1997) Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study. J Clin Endocrinol Metab 82:2102\u20132107","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"997_CR6","doi-asserted-by":"crossref","first-page":"e5833","DOI":"10.1097\/MD.0000000000005833","volume":"96","author":"YJ Song","year":"2017","unstructured":"Song YJ, Chen MT, Lian W et al (2017) Surgical treatment for male prolactinoma: a retrospective study of 184 cases. Medicine (Baltimore) 96(2):e5833","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"997_CR7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/cen.12242","volume":"79","author":"AB Moraes","year":"2013","unstructured":"Moraes AB, Silva CM, Vieira Neto L et al (2013) Giant prolactinomas: the therapeutic approach. Clin Endocrinol (Oxf) 79(4):447\u2013456","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"997_CR8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00431-017-3042-5","volume":"177","author":"A Hoffmann","year":"2018","unstructured":"Hoffmann A, Adelmann S, Lohle K et al (2018) Pediatric prolactinoma: initial presentation, treatment, and long-term prognosis. Eur J Pediatr 177(1):125\u2013132","journal-title":"Eur J Pediatr"},{"issue":"3","key":"997_CR9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000357673","volume":"81","author":"F Guaraldi","year":"2014","unstructured":"Guaraldi F, Storr HL, Ghizzoni L et al (2014) Paediatric pituitary adenomas: a decade of change. Horm Res Paediatr 81(3):145\u2013155","journal-title":"Horm Res Paediatr"},{"issue":"6","key":"997_CR10","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00381-015-2679-5","volume":"31","author":"Y Liu","year":"2015","unstructured":"Liu Y, Yao Y, Xing B, Lian W, et al (2015) Prolactinomas in children under 14. Clinical presentation and long-term follow-up. Childs Nerv Syst 31(6):909\u2013916","journal-title":"Childs Nerv Syst"},{"issue":"3","key":"997_CR11","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1210\/jc.2014-3670","volume":"100","author":"S Salenave","year":"2015","unstructured":"Salenave S, Ancelle D, Bahougne T et al (2015) Macroprolactinomas in children and adolescents: factors associated with the response to treatment in 77 patients. J Clin Endocrinol Metab 100(3):1177\u20131186","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"997_CR12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1210\/er.2012-1013","volume":"34","author":"A Beckers","year":"2013","unstructured":"Beckers A, Aaltonen LA, Daly AF et al (2013) Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene. Endocr Rev 34(2):239\u2013277","journal-title":"Endocr Rev"},{"issue":"1","key":"997_CR13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000371819","volume":"103","author":"MH Schernthaner-Reiter","year":"2016","unstructured":"Schernthaner-Reiter MH, Trivellin G et al (2016) MEN1, MEN4, and Carney Complex: pathology and molecular genetics. Neuroendocrinology 103(1):18\u201331","journal-title":"Neuroendocrinology"},{"key":"997_CR14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/B978-0-444-59602-4.00023-X","volume":"124","author":"N Alband","year":"2014","unstructured":"Alband N, Korbonits M (2014) Familial pituitary tumors. Handb Clin Neurol 124:339\u2013360","journal-title":"Handb Clin Neurol"},{"issue":"2","key":"997_CR15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"Melmed S, Casanueva FF, Hoffman AR, et al (2011) Endocrine Society. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(2):273\u2013288","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"997_CR16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.beem.2009.05.003","volume":"23","author":"A Colao","year":"2009","unstructured":"Colao A (2009) Pituitary tumours: the prolactinoma. Best Pract Res Clin Endocrinol Metab 23(5):575\u2013596","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"10","key":"997_CR17","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jocn.2015.03.059","volume":"22","author":"A Wong","year":"2015","unstructured":"Wong A, Eloy JA, Couldwell WT, et al (2015) Update on prolactinomas. Part 2: treatment and management strategies. J Clin Neurosci 22(10):1568\u20131574","journal-title":"J Clin Neurosci"},{"key":"997_CR18","first-page":"24","volume-title":"WHO classification of tumours of endocrine organs","author":"V Nos\u00e9","year":"2017","unstructured":"Nos\u00e9 V, Grossman A, Mete O (2017) Lactotroph adenoma. In: Lloyd RV, Osamura RY, Kloppel G, Rosai J (eds) WHO classification of tumours of endocrine organs, 4th edn. IARC Press, Lyon, pp 24\u201327","edition":"4"},{"issue":"4","key":"997_CR19","first-page":"605","volume":"32","author":"RY Osamura","year":"1982","unstructured":"Osamura RY, Watanabe K, Komatsu N et al (1982) Amorphous and stellate amyloid in functioning human pituitary adenomas: histochemical, immunohistochemical and electron microscopic studies. Acta Pathol Jpn 32(4):605\u2013611","journal-title":"Acta Pathol Jpn"},{"issue":"1","key":"997_CR20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s004280050212","volume":"433","author":"K Steusloff","year":"1998","unstructured":"Steusloff K, R\u00f6cken C, Saeger W (1998) Basement membrane proteins, apolipoprotein E and glycosaminoglycans in pituitary adenomas and their correlation to amyloid. Virchows Arch 433(1):29\u201334","journal-title":"Virchows Arch"},{"key":"997_CR21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/jemt.1070200202","volume":"20","author":"E Horvath","year":"1992","unstructured":"Horvath E, Kovacs K (1992) Ultrastructural diagnosis of human pituitary adenomas. Microsc Res Tech 20:107\u2013135","journal-title":"Microsc Res Tech"},{"key":"997_CR22","first-page":"1497","volume":"78","author":"KE Friend","year":"1994","unstructured":"Friend KE, Chiou YK, Lopes MB et al (1994) Estrogen receptor expression in human pituitary: correlation with immunohistochemistry in normal tissue, and immunohistochemistry and morphology in macroadenomas. J Clin Endocrinol Metab 78:1497\u20131504","journal-title":"J Clin Endocrinol Metab"},{"key":"997_CR23","first-page":"3621","volume":"80","author":"M Zafar","year":"1995","unstructured":"Zafar M, Ezzat S, Ramyar L et al (1995) Cell-specific expression of estrogen receptor in the human pituitary and its adenomas. J Clin Endocrinol Metab 80:3621\u20133627","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"997_CR24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1023\/A:1009903603495","volume":"1","author":"GJ Kaptain","year":"1999","unstructured":"Kaptain GJ, Simmons NE, Alden TD et al (1999) Estrogen receptors in prolactinomas: a clinico-pathological study. Pituitary 1(2):91\u201398","journal-title":"Pituitary"},{"issue":"8","key":"997_CR25","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1055\/s-2008-1065338","volume":"40","author":"JA Burdman","year":"2008","unstructured":"Burdman JA, Pauni M, Heredia Sereno GM et al (2008) Estrogen receptors in human pituitary tumors. Horm Metab Res 40(8):524\u2013527","journal-title":"Horm Metab Res"},{"issue":"7","key":"997_CR26","first-page":"2897","volume":"30","author":"B Manoranjan","year":"2010","unstructured":"Manoranjan B, Salehi F, Scheithauer BW et al (2010) Estrogen receptors alpha and beta immunohistochemical expression: clinicopathological correlations in pituitary adenomas. Anticancer Res 30(7):2897\u20132904","journal-title":"Anticancer Res"},{"issue":"6","key":"997_CR27","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1530\/EJE-14-0990","volume":"172","author":"E Delgrange","year":"2015","unstructured":"Delgrange E, Vasiljevic A, Wierinckx A et al (2015) Expression of estrogen receptor alpha is associated with prolactin pituitary tumor prognosis and supports the sex-related difference in tumor growth. Eur J Endocrinol 172(6):791\u2013801","journal-title":"Eur J Endocrinol"},{"key":"997_CR28","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/1097-0142(19810215)47:4<761::AID-CNCR2820470422>3.0.CO;2-L","volume":"47","author":"E Horvath","year":"1981","unstructured":"Horvath E, Kovacs K, Singer W et al (1981) Acidophil stem cell adenoma of the human pituitary: clinico-pathological analysis of 15 cases. Cancer 47:761\u2013771","journal-title":"Cancer"},{"key":"997_CR29","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1210\/jcem.86.9.7819","volume":"86","author":"J Kreutzer","year":"2001","unstructured":"Kreutzer J, Vance ML, Lopes MBS et al (2001) Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria. J Clin Endocrinol Metabol 86:4072\u20134077","journal-title":"J Clin Endocrinol Metabol"},{"key":"997_CR30","first-page":"41","volume-title":"WHO classification of tumours of endocrine organs","author":"F Roncaroli","year":"2017","unstructured":"Roncaroli F, Kovacs K, Lloyd RV et al (2017) Pituitary carcinoma. In: Lloyd RV, Osamura RY, Kloppel G, Rosai J (eds) WHO classification of tumours of endocrine organs, 4th edn. IARC Press, Lyon, pp 41\u201344","edition":"4"},{"key":"997_CR31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/eje.1.02326","volume":"156","author":"W Saeger","year":"2007","unstructured":"Saeger W, L\u00fcdecke DK, Buchfelder M et al (2007) Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol 156:203\u2013216","journal-title":"Eur J Endocrinol"},{"key":"997_CR32","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40478-015-0229-8","volume":"3","author":"CP Miermeister","year":"2015","unstructured":"Miermeister CP, Petersenn S, Buchfelder M, et al (2015) Histological criteria for atypical pituitary adenomas\u2014data from the German pituitary adenoma registry suggests modifications. Acta Neuropathol Commun 3:50. Erratum in: Acta Neuropathol Commun. 2016;4(1):21","journal-title":"Acta Neuropathol Commun"},{"key":"997_CR33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/BF01605931","volume":"418","author":"K Kovacs","year":"1991","unstructured":"Kovacs K, Stefaneanu L, Horvath E et al (1991) Effect of dopamine agonist medication on prolactin producing adenomas: a morphological study including immunocytochemistry, electron microscopy and in situ hybridization. Virchows Arch A 418:439\u2013446","journal-title":"Virchows Arch A"},{"issue":"11","key":"997_CR34","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jocn.2015.06.001","volume":"22","author":"TR Smith","year":"2015","unstructured":"Smith TR, Hulou MM, Huang KT et al (2015) Current indications for the surgical treatment of prolactinomas. J Clin Neurosci 22(11):1785\u20131791","journal-title":"J Clin Neurosci"},{"key":"997_CR35","first-page":"9","volume-title":"World Health Organization classification of tumours: pathology and genetics of tumours of endocrine organs","author":"RA DeLellis","year":"2004","unstructured":"DeLellis RA, Lloyd RV, Heitz PU et al (2004) World Health Organization classification of tumours: pathology and genetics of tumours of endocrine organs. IARC Press, Lyon, France, pp 9\u201347"},{"issue":"4","key":"997_CR36","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1210\/jc.2009-1191","volume":"95","author":"G Raverot","year":"2010","unstructured":"Raverot G, Wierinckx A, Dantony E et al (2010) Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up. J Clin Endocrinol Metab 95(4):1708\u20131716","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"997_CR37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10143-016-0740-9","volume":"40","author":"MDB De Caro","year":"2017","unstructured":"De Caro MDB, Solari D, et al (2017) Atypical pituitary adenomas: clinical characteristics and role of ki-67 and p53 in prognostic and therapeutic evaluation. A series of 50 patients. Neurosurg Rev 40(1):105\u2013114","journal-title":"Neurosurg Rev"},{"key":"997_CR38","first-page":"13","volume-title":"WHO classification of tumours of endocrine organs","author":"RY Osamura","year":"2017","unstructured":"Osamura RY, Lopes MBS, Grossman A et al (2017) Introduction. In: Lloyd RV, Osamura RY, Kloppel G, Rosai J (eds) WHO classification of tumours of endocrine organs, 4th edn. IARC Press, Lyon, p 13","edition":"4"},{"issue":"2","key":"997_CR39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.0007-1331.2001.00744.x","volume":"14","author":"MA Shupnik","year":"2002","unstructured":"Shupnik MA (2002) Oestrogen receptors, receptor variants and oestrogen actions in the hypothalamic-pituitary axis. J Neuroendocrinol 14(2):85\u201394","journal-title":"J Neuroendocrinol"},{"issue":"11","key":"997_CR40","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.4065\/73.11.1046","volume":"73","author":"RD Calle-Rodrigue","year":"1998","unstructured":"Calle-Rodrigue RD, Giannini C, Scheithauer BW et al (1998) Prolactinomas in male and female patients: a comparative clinicopathologic study. Mayo Clin Proc 73(11):1046\u20131052","journal-title":"Mayo Clin Proc"},{"key":"997_CR41","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1210\/jcem.86.11.8054","volume":"86","author":"A Di Sarno","year":"2001","unstructured":"Di Sarno A, Landi ML, Cappabianca P et al (2001) Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy. J Clin Endocrinol Metab 86:5256\u20135261","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"997_CR42","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3171\/2010.11.JNS101369","volume":"114","author":"MC Oh","year":"2011","unstructured":"Oh MC, Aghi MK (2011) Dopamine agonist-resistant prolactinomas. J Neurosurg 114(5):1369\u20131379","journal-title":"J Neurosurg"},{"key":"997_CR43","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1530\/EJE-09-0012","volume":"160","author":"E Delgrange","year":"2009","unstructured":"Delgrange E, Daems T, Verhelst J et al (2009) Characterization of resistance to the prolactin-lowering effects of cabergoline in macroprolactinomas: a study in 122 patients. Eur J Endocrinol 160:747\u2013752","journal-title":"Eur J Endocrinol"},{"key":"997_CR44","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00701-005-0498-2","volume":"147","author":"E Delgrange","year":"2005","unstructured":"Delgrange E, Sassolas G, Perrin G et al (2005) Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance. Acta Neurochir (Wien) 147:751\u2013758","journal-title":"Acta Neurochir (Wien)"},{"issue":"5","key":"997_CR45","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s11102-018-0898-y","volume":"21","author":"W Liu","year":"2018","unstructured":"Liu W, Zahr RS, McCartney S et al (2018) Clinical outcomes in male patients with lactotroph adenomas who required pituitary surgery: a retrospective single center study. Pituitary 21(5):454\u2013462","journal-title":"Pituitary"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-019-00997-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-019-00997-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-019-00997-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T23:21:47Z","timestamp":1603236107000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-019-00997-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,22]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["997"],"URL":"https:\/\/doi.org\/10.1007\/s11102-019-00997-1","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,22]]},"assertion":[{"value":"22 October 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares that she has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This paper does not contain any studies with human participants or animals performed by the author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}}]}}